• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression analysis of glycogen synthase kinase-3 in human tissues.

作者信息

Lau K F, Miller C C, Anderton B H, Shaw P C

机构信息

Department of Biochemistry, The Chinese University of Hong Kong, Shatin.

出版信息

J Pept Res. 1999 Jul;54(1):85-91. doi: 10.1034/j.1399-3011.1999.00083.x.

DOI:10.1034/j.1399-3011.1999.00083.x
PMID:10448973
Abstract

Human glycogen synthase kinase-3 (GSK-3) is a multisubstrate, proline-directed kinase that phosphorylates tau, beta-amyloid and neurofilaments. In this study, the expression levels of the two GSK-3 isoforms, alpha and beta, RNA and proteins in different human tissues were examined. Northern analysis demonstrated that GSK-3alpha is encoded by a 2.6-kb mRNA and GSK-3beta by 8.3- and 2.8-kb mRNAs. The two GSK-3beta mRNA species were variably expressed in different tissues. Northern and quantitative polymerase chain reaction demonstrated that both GSK-3alpha and GSK-3beta mRNA were prominently expressed in testis, thymus, prostate and ovary but were low in adult lung and kidney. Western blot analysis showed that the 51-kDa GSK-3alpha protein was highly expressed in lung, ovary, kidney and testis, whereas the 46-kDa GSK-3beta protein was highly expressed in lung, kidney and brain. The differential expression of GSK-3alpha and GSK-3beta mRNA and proteins and the lack of relationship between transcription and translation in some tissues indicate that GSK-3alpha and GSK-3beta are subject to different means of regulation.

摘要

相似文献

1
Expression analysis of glycogen synthase kinase-3 in human tissues.
J Pept Res. 1999 Jul;54(1):85-91. doi: 10.1034/j.1399-3011.1999.00083.x.
2
Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain.糖原合酶激酶-3亚型在小鼠组织中的表达及其在脑中的转录。
J Chem Neuroanat. 2002 May;23(4):291-7. doi: 10.1016/s0891-0618(02)00014-5.
3
Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.人糖原合酶激酶-3β启动子的分子克隆与特性分析
Genomics. 1999 Sep 1;60(2):121-8. doi: 10.1006/geno.1999.5875.
4
Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes.
Genome. 1998 Oct;41(5):720-7.
5
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
Neuroreport. 1997 Oct 20;8(15):3251-5. doi: 10.1097/00001756-199710200-00013.
6
Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.淀粉样β肽(25-35)激活tau蛋白激酶I/糖原合酶激酶-3β可增强海马神经元中tau的磷酸化。
Neurosci Res. 1998 Aug;31(4):317-23. doi: 10.1016/s0168-0102(98)00061-3.
7
Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues.神经组织和非神经组织中糖原合酶激酶3β(GSK-3β)的基因结构与可变剪接
Gene. 2003 Jan 2;302(1-2):73-81. doi: 10.1016/s0378-1119(02)01092-2.
8
Inhibition of alanyl-aminopeptidase suppresses the activation-dependent induction of glycogen synthase kinase-3beta (GSK-3beta) in human T cells.抑制丙氨酰氨肽酶可抑制人T细胞中糖原合酶激酶-3β(GSK-3β)的激活依赖性诱导。
Biochem Biophys Res Commun. 2000 Jun 24;273(1):62-5. doi: 10.1006/bbrc.2000.2883.
9
The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.糖原合酶激酶-3β的活性形式与阿尔茨海默病神经元中的颗粒空泡变性有关。
Acta Neuropathol. 2002 Feb;103(2):91-9. doi: 10.1007/s004010100435. Epub 2001 Nov 29.
10
Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM.非胰岛素依赖型糖尿病患者糖原合酶激酶-3α和β亚型编码区的染色体定位及突变分析
Diabetologia. 1997 Aug;40(8):940-6. doi: 10.1007/s001250050771.

引用本文的文献

1
Radiosynthesis and evaluation of a novel F-labeled tracer for PET imaging of glycogen synthase kinase 3.用于糖原合酶激酶3正电子发射断层显像的新型F标记示踪剂的放射性合成与评价
Am J Nucl Med Mol Imaging. 2024 Oct 15;14(5):327-336. doi: 10.62347/OBZS8887. eCollection 2024.
2
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.锂的药理学和毒理学的新进展:神经生物学导向的概述。
Pharmacol Rev. 2024 May 2;76(3):323-357. doi: 10.1124/pharmrev.120.000007.
3
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.
了解糖原合成酶激酶-3:阿尔茨海默病的新途径。
Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8.
4
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.GSK3 是视网膜退行性疾病的核心参与者,但却是一个具有挑战性的治疗靶点。
Cells. 2022 Sep 16;11(18):2898. doi: 10.3390/cells11182898.
5
Glycogen Synthase Kinase-3 Isoform Variants and Their Inhibitory Phosphorylation in Human Testes and Spermatozoa.糖原合酶激酶-3亚型变体及其在人类睾丸和精子中的抑制性磷酸化
World J Mens Health. 2023 Jan;41(1):215-226. doi: 10.5534/wjmh.220108. Epub 2022 Aug 16.
6
The GSK-3 Inhibitor CT99021 Enhances the Acquisition of Spatial Learning and the Accuracy of Spatial Memory.葛兰素史克公司的糖原合成酶激酶-3抑制剂CT99021可增强空间学习能力的获得及空间记忆的准确性。
Front Mol Neurosci. 2022 Jan 27;14:804130. doi: 10.3389/fnmol.2021.804130. eCollection 2021.
7
Therapeutic Mechanism and Key Alkaloids of in Alzheimer's Disease From the Perspective of Pathophysiological Processes.从病理生理过程角度看阿尔茨海默病的治疗机制及关键生物碱
Front Pharmacol. 2021 Dec 15;12:806984. doi: 10.3389/fphar.2021.806984. eCollection 2021.
8
Mechanistic insights into the anti-depressant effect of emodin: an integrated systems pharmacology study and experimental validation.大黄素抗抑郁作用的机制研究:整合系统药理学研究和实验验证。
Aging (Albany NY). 2021 May 29;13(11):15078-15099. doi: 10.18632/aging.203072.
9
GSK-3 and Tau: A Key Duet in Alzheimer's Disease.GSK-3 和 Tau:阿尔茨海默病中的关键二重奏。
Cells. 2021 Mar 24;10(4):721. doi: 10.3390/cells10040721.
10
GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness.GSK3β:在抑郁障碍发病机制和治疗反应中的主控者
Cells. 2020 Mar 16;9(3):727. doi: 10.3390/cells9030727.